Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

10.1186/s12885-016-2395-x

Saved in:
Bibliographic Details
Main Authors: De Groot, S, Sleijfer, S, Redekop, W.K, Oosterwijk, E, Haanen, J.B.A.G, Kiemeney, L.A.L.M, Uyl-de Groot, C.A
Other Authors: SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format: Article
Published: 2020
Subjects:
age
Online Access:https://scholarbank.nus.edu.sg/handle/10635/181363
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-181363
record_format dspace
spelling sg-nus-scholar.10635-1813632023-10-31T20:54:53Z Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry De Groot, S Sleijfer, S Redekop, W.K Oosterwijk, E Haanen, J.B.A.G Kiemeney, L.A.L.M Uyl-de Groot, C.A SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH alpha interferon bevacizumab everolimus pazopanib sorafenib sunitinib temsirolimus antineoplastic agent indole derivative pazopanib pyrimidine derivative pyrrole derivative sulfonamide sunitinib adult age aged Article bone metastasis brain metastasis cancer prognosis cancer registry cancer survival clinical effectiveness clinical practice cohort analysis controlled study drug use drug utilization female high risk population human kidney carcinoma liver metastasis lung metastasis major clinical study male metastasis metastasis resection molecularly targeted therapy nephrectomy Netherlands number of metastatic site oncological parameters overall survival survival time systemic therapy trend study Carcinoma, Renal Cell Kidney Neoplasms middle aged molecularly targeted therapy prescription register retrospective study statistical model survival analysis treatment outcome very elderly young adult Adult Aged Aged, 80 and over Antineoplastic Agents Carcinoma, Renal Cell Drug Prescriptions Female Humans Indoles Kidney Neoplasms Logistic Models Male Middle Aged Molecular Targeted Therapy Netherlands Pyrimidines Pyrroles Registries Retrospective Studies Sulfonamides Survival Analysis Treatment Outcome Young Adult 10.1186/s12885-016-2395-x BMC Cancer 16 1 364 2020-10-27T10:41:57Z 2020-10-27T10:41:57Z 2016 Article De Groot, S, Sleijfer, S, Redekop, W.K, Oosterwijk, E, Haanen, J.B.A.G, Kiemeney, L.A.L.M, Uyl-de Groot, C.A (2016). Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry. BMC Cancer 16 (1) : 364. ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-016-2395-x 14712407 https://scholarbank.nus.edu.sg/handle/10635/181363 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic alpha interferon
bevacizumab
everolimus
pazopanib
sorafenib
sunitinib
temsirolimus
antineoplastic agent
indole derivative
pazopanib
pyrimidine derivative
pyrrole derivative
sulfonamide
sunitinib
adult
age
aged
Article
bone metastasis
brain metastasis
cancer prognosis
cancer registry
cancer survival
clinical effectiveness
clinical practice
cohort analysis
controlled study
drug use
drug utilization
female
high risk population
human
kidney carcinoma
liver metastasis
lung metastasis
major clinical study
male
metastasis
metastasis resection
molecularly targeted therapy
nephrectomy
Netherlands
number of metastatic site
oncological parameters
overall survival
survival time
systemic therapy
trend study
Carcinoma, Renal Cell
Kidney Neoplasms
middle aged
molecularly targeted therapy
prescription
register
retrospective study
statistical model
survival analysis
treatment outcome
very elderly
young adult
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Renal Cell
Drug Prescriptions
Female
Humans
Indoles
Kidney Neoplasms
Logistic Models
Male
Middle Aged
Molecular Targeted Therapy
Netherlands
Pyrimidines
Pyrroles
Registries
Retrospective Studies
Sulfonamides
Survival Analysis
Treatment Outcome
Young Adult
spellingShingle alpha interferon
bevacizumab
everolimus
pazopanib
sorafenib
sunitinib
temsirolimus
antineoplastic agent
indole derivative
pazopanib
pyrimidine derivative
pyrrole derivative
sulfonamide
sunitinib
adult
age
aged
Article
bone metastasis
brain metastasis
cancer prognosis
cancer registry
cancer survival
clinical effectiveness
clinical practice
cohort analysis
controlled study
drug use
drug utilization
female
high risk population
human
kidney carcinoma
liver metastasis
lung metastasis
major clinical study
male
metastasis
metastasis resection
molecularly targeted therapy
nephrectomy
Netherlands
number of metastatic site
oncological parameters
overall survival
survival time
systemic therapy
trend study
Carcinoma, Renal Cell
Kidney Neoplasms
middle aged
molecularly targeted therapy
prescription
register
retrospective study
statistical model
survival analysis
treatment outcome
very elderly
young adult
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Renal Cell
Drug Prescriptions
Female
Humans
Indoles
Kidney Neoplasms
Logistic Models
Male
Middle Aged
Molecular Targeted Therapy
Netherlands
Pyrimidines
Pyrroles
Registries
Retrospective Studies
Sulfonamides
Survival Analysis
Treatment Outcome
Young Adult
De Groot, S
Sleijfer, S
Redekop, W.K
Oosterwijk, E
Haanen, J.B.A.G
Kiemeney, L.A.L.M
Uyl-de Groot, C.A
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
description 10.1186/s12885-016-2395-x
author2 SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
author_facet SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
De Groot, S
Sleijfer, S
Redekop, W.K
Oosterwijk, E
Haanen, J.B.A.G
Kiemeney, L.A.L.M
Uyl-de Groot, C.A
format Article
author De Groot, S
Sleijfer, S
Redekop, W.K
Oosterwijk, E
Haanen, J.B.A.G
Kiemeney, L.A.L.M
Uyl-de Groot, C.A
author_sort De Groot, S
title Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
title_short Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
title_full Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
title_fullStr Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
title_full_unstemmed Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
title_sort variation in use of targeted therapies for metastatic renal cell carcinoma: results from a dutch population-based registry
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/181363
_version_ 1781792487457685504